SUBSCRIBE
SUBSCRIBE

Asia

Indonesia Orders Overhaul Of Drug Agency After Fake Vaccine Scandal
July 15, 2016
 · 
1 min read
Pregnant Women Carrying A Boy May Be At Risk For Preterm Birth, University of Adelaide Study
July 13, 2016
 · 
1 min read
Why Artificial Sweeteners Can Increase Your Appetite, University of Sydney Study
July 13, 2016
 · 
2 min read
New Eye Test Could Detect Glaucoma Years Earlier, University of New South Wales Study
July 13, 2016
 · 
2 min read
Nanotech “Tattoo” Can Map Emotions and Monitor Muscle Activity, Tel Aviv University Study
July 12, 2016
 · 
2 min read
Validate Personal Air-Pollution Sensors
July 11, 2016
 · 
1 min read
Bypass Surgery Could Reverse Diabetes By Improving The Body’s Response To Insulin, Nanjing University Study
July 11, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Japan’s Nichi-Iko Takes Out Sagent Pharma for $736 Million Cash
July 11, 2016
 · 
2 min read
Gene Mutation Could Ruin Japanese Sake, University of Tokyo Study
July 8, 2016
 · 
1 min read
Perception Of Body Size Can Change In Only Two Minutes, Macquarie University Study
July 8, 2016
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe
January 22, 2026
 · 
3 min read
Press Releases
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
January 22, 2026
 · 
10 min read
Press Releases
Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position
January 21, 2026
 · 
5 min read
Press Releases
ProImmune Introduces Mastering Immunity 2026 - Shanghai Symposium to Address Key Immunogenicity Challenges
January 21, 2026
 · 
2 min read
Press Releases
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
January 21, 2026
 · 
5 min read
Press Releases
HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services
January 21, 2026
 · 
3 min read
Press Releases
Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
January 21, 2026
 · 
4 min read
Press Releases
Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1
January 20, 2026
 · 
7 min read
Press Releases
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
January 20, 2026
 · 
6 min read
Press Releases
Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development
January 20, 2026
 · 
4 min read
Press Releases
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders
January 20, 2026
 · 
6 min read
Press Releases
LexBio Named One of Ten “Honored Enterprises” in NVIDIA Inception Showcase 2025
January 19, 2026
 · 
1 min read
Press Releases
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene’s NouvNeu001, Making It the World’s First iPSC Therapy with Both FTD and RMAT Recognitions
January 19, 2026
 · 
5 min read
Press Releases
Akeso Announces NMPA Acceptance of Second NDA for Gumokimab (IL-17A Inhibitor) in Active Ankylosing Spondylitis
January 19, 2026
 · 
4 min read
Press Releases
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
January 19, 2026
 · 
10 min read
Press Releases
Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea
January 19, 2026
 · 
7 min read
Press Releases
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
January 19, 2026
 · 
2 min read
Press Releases
AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
January 19, 2026
 · 
3 min read
Press Releases
D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
January 19, 2026
 · 
3 min read
Press Releases
2026 China FIC Innovation and Collaboration Summit Held in San Francisco, Chinese Pharmaceutical Companies Showcase Innovative Achievements
January 19, 2026
 · 
7 min read
Load More